Raymond Gilmartin

Last updated

Raymond Gilmartin
BornMarch 6, 1941 (1941-03-06) (age 80)
Sayville, New York
Occupationprofessor at Harvard Business School, former President & CEO of Merck & Co, Inc.
Board member of Microsoft, General Mills
Spouse(s)Gladys Higham, 1965
ChildrenThree children

Raymond V. Gilmartin (born March 6, 1941) is an American former business executive and an adjunct professor of management practice at the Harvard Business School.

Contents

Biography

Early life

Raymond Gilmartin was born on March 6, 1941, in Sayville, New York. [1] He received his B.S. in electrical engineering from Union College in 1963, being the first member of his immediate family to attend college, [1] and an MBA from Harvard Business School in 1968. [2] In the interim between colleges, he worked as an engineer at Kodak and met his future wife. [1]

Family life

Gilmartin married Gladys Higham in 1965, and had three children as of 2005. [1] Gilmartin has been a resident of Park Ridge, New Jersey. [3] [4]

Career

After graduation from Harvard, Gilmartin worked as a consultant at Arthur D. Little for eight years. [1]

Gilmartin joined Becton Dickinson (BD) in 1976 as a vice president and rose to hold president, chairman and CEO positions at the company by the time of his departure in 1994. [2] [5] Gilmartin's work at BD has been considered instrumental in supporting the company's transition from a regional to a multinational company. [1] Gilmartin then moved to Merck & Co, Inc., hired as president and CEO in 1994, and adding the role of chairman the same year upon retirement of P. Roy Vagelos. [1] [2]

The style of management that I have, basically, is to recognize the fact that I'll never be as expert in any of the areas of the company as some of my direct reports are.

Raymond Gilmartin,Interview for The Record (Bergen County, New Jersey), October 2003 [1]

Gilmartin's new position at Merck was a shock to pharmaceutical industry analysts as he was the first CEO ever recruited from outside the company since its founding in 1891, and despite his having managed at BD, Gilmartin was considered a newcomer to the pharmaceutical industry. [1] During his tenure, Gilmartin oversaw Merck's response to two patent cliffs and consistently rejected the prospect of merging the company with a rival and maintained an emphasis on original research as opposed to joining a growing trend of in-licensing late-state drug prospects. [1] Gilmartin's management style was characterized by delegation of day-to-day activities while maintaining a focus on strategic planning and decision making. [1]

Gilmartin served at Merck until May 2005, a period which included the Vioxx scandal; thereafter, he remained with Merck in an advisory capacity until April 2006, when his retirement became effective. [2] Late in his tenure at Merck, in 2004, Gilmartin received an LL.D. (honorary) from Kean University of New Jersey. [1]

In July 2006, Gilmartin became a professor of management practices at Harvard Business School. [5] Gilmartin has also served as a member of the board of advisors to the dean of Harvard Business School. [2]

Gilmartin joined the board of directors of Microsoft in 2001. [2] Other boards that Gilmartin has served on include that of directors at General Mills, the National Association of Corporate Directors [6] and the United Negro College Fund, [1] [5] and trustees at the American Enterprise Institute. [7] Gilmartin has also served as a chair of PhRMA and president of IFPMA. [2]

Further reading

Related Research Articles

Ernesto Bertarelli Swiss-Italian billionaire

Ernesto Bertarelli is an Italian-born Swiss billionaire businessman and philanthropist.

John W. Thompson

John Wendell Thompson is an American technology executive who was the chair of Microsoft from 2014 until June 2021, and chair of Illumina since 2021. He is a former chief executive of Virtual Instruments, a vice-president at IBM and the former chief executive of Symantec. Thompson later became an independent director on the board of Microsoft, and in February 2014, was named chairman. He led the search for Microsoft's next CEO; as a result, Satya Nadella was selected.

Richard Clark (business executive)

Richard T. Clark is a former chairman of the Merck & Co. (MSD) pharmaceutical company, a position he held from 2007 to 2011. His previous leadership positions at Merck & Co. include CEO (2005–2010), President (2005–2009), and president of the Merck & Co. manufacturing division (2003–2005).

Kevin W. Sharer is an American businessman who was chairman/CEO of the biotechnology company Amgen from 2000 to 2012. He also served on several large company boards of directors, and after Amgen, he joined the faculty of Harvard Business School teaching RC Strategy and General Management: Processes and Action.

Patricia Russo

Patricia F. Russo is an American businessperson. Russo is most widely known for having served as chief executive officer of Lucent Technologies, and its successor, Alcatel-Lucent, a large communications equipment manufacturer. As of 2020, she serves on the board of directors of General Motors, Merck & Co., and Arconic, Inc. She serves as chairwoman of the nonprofit organization, Partnership at Drugfree.org. Prior to the split of Hewlett-Packard into two companies in 2015, Russo served as lead independent director. She now serves as chairwoman of Hewlett Packard Enterprise.

George Wilhelm Herman Emanuel Merck was the president of Merck & Co. from 1925 to 1950 and member of Merck family.

Delbert W. Yocam was a US technology executive. Yocam is a former chairman and CEO of Borland, former president, COO and director of Tektronix and a former Apple Computer executive. At Apple, during the 1980s, Yocam ran the Apple II group and later became Apple's first chief operating officer (COO). He served on the board of directors at Adobe Systems.

K. V. Kamath

Kundapur Vaman Kamath, commonly referred to as K. V. Kamath, was the former chief of the New Development Bank of BRICS countries, previously he has also served as the Chairman of Infosys Limited, the second-largest Indian IT services company, and as the Non-Executive Chairman of ICICI Bank, India's largest private bank. Kamath also served as ICICI Bank's founder and Managing Director and CEO from 1 May 1996 until his retirement from executive responsibilities on 30 April 2009.

Butterfield, officially The Bank of N. T. Butterfield & Son Limited, is a bank founded and based in Bermuda. It provides services to clients from Bermuda, the Cayman Islands, Guernsey and Jersey, where its principal banking operations are located, and The Bahamas, Switzerland, Singapore and the United Kingdom, where it offers specialized financial services. Banking services comprise deposit, cash management and lending for individual, business and institutional clients. Wealth management services are composed of trust, private banking, asset management and custody. In Bermuda, the Cayman Islands and Guernsey, Butterfield offers both banking and wealth management. In The Bahamas, Singapore and Switzerland, Butterfield offers select wealth management services. In the UK, Butterfield offers residential property lending. In Jersey, it offers banking and wealth management services. Butterfield is publicly traded on the New York Stock Exchange and the Bermuda Stock Exchange .]</ref>

Fred Hassan, is a business executive who works for Warburg Pincus and was CEO of three global pharmaceutical companies.

Peter Löscher Austrian manager (born 1957)

Peter Löscher is an Austrian manager who was the CEO of Siemens from 2007 until 2013. As of 2017, Löscher remains as the only CEO to be hired from outside the conglomerate in the 170-year history of Siemens. Before joining Siemens, he worked as president for Global Human Health at global pharmaceutical company Merck & Co.

John Lloyd Huck was a business executive, philanthropist, and aviation enthusiast. He was chairman of pharmaceutical firms Merck & Co. and Nova Pharmaceutical Corporation, as well as Mutual Benefit Life Insurance Company.

Kenneth Frazier American business executive

Kenneth Carleton Frazier is an American business executive. He is executive chairman and former CEO of the pharmaceutical company Merck & Co.. After joining Merck & Co. as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first African American man to lead a major pharmaceutical company. He was elected to the American Philosophical Society in 2018.

David B. Snow Jr. is an American business executive currently serving as the chairman and chief executive officer (CEO) of Cedar Gate Technologies, a healthcare predictive and prescriptive analytics company. He previously served as the CEO of Medco Health Solutions, the sixth largest pharmaceutical company in the United States by revenue. He founded Americhoice, a drug development company he sold to UnitedHealth Group for $570 million.

Rutgers Business School – Newark and New Brunswick is the graduate and undergraduate business school located on the Newark and New Brunswick campuses of Rutgers University. It was founded in 1929. It operated under several different names before consolidating into Rutgers Business School.

Richard Kogan is an American businessman. He served as the president and chief executive officer of Schering-Plough from 1996 to 2003, and its chairman from 1998 to 2002.

John C. Lechleiter is an American businessman and chemist. He served as the President, Chief Executive Officer and Chairman of the Board of Directors of Eli Lilly and Company from April 2008 to December 2016. John Lechleiter's successor is David Ricks who assumed the role of president and CEO in January 2017. He is the eldest of nine children of Jeanne and John H. Lechleiter.

Brenton L. Saunders, also known as Brent Saunders, is the CEO of Vesper Healthcare Acquisition Corp. He was previously CEO of the pharmaceutical company Allergan, the CEO and president of Forest Laboratories, and the CEO of Bausch + Lomb Incorporated.

Greg Maffei American businessman (born 1960)

Greg Maffei is an American businessman. He is the president and chief executive officer of Liberty Media and the chairman of Live Nation Entertainment, Sirius XM and TripAdvisor. He is the chairman emeritus of Starz and Expedia, as well as the former chief financial officer of Oracle and Microsoft.

Michael Bonney

Michael "Mike" Weston Bonney is an American businessman and former pharmaceutical executive. Bonney was the president and chief executive officer of Cubist Pharmaceuticals, from 2003 until his retirement in 2014 coinciding with the company being acquired by Merck & Co. for $9.5 billion.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 Petechuk, David (2005). "Gilmartin, Raymond V. 1941-". In Schlager, Neil (ed.). International Directory of Business Biographies . 2. Detroit, Michigan: St. James Press. pp. 135–139. Retrieved August 7, 2020– via Gale eBooks.
  2. 1 2 3 4 5 6 7 "Raymond V. Gilmartin". Microsoft News Center. Microsoft. 2007. Archived from the original on July 8, 2012.
  3. ↑ Staff. "WEDDINGS/CELEBRATIONS; Beth Gilmartin, Michael Neumann", The New York Times , May 2, 2004. Accessed September 16, 2015. "She is a daughter of Gladys and Raymond Gilmartin of Park Ridge, N.J. Her father is the chairman and chief executive of Merck & Company, the pharmaceuticals company in Whitehouse Station, N.J."
  4. ↑ "Raymond V. Gilmartin: Man with a global vision", Union College, August 9, 2004. Accessed September 16, 2015. "HOME: Park Ridge, N.J."
  5. 1 2 3 "Raymond Gilmartin". Profiles. Forbes. Archived from the original on June 9, 2013.
  6. ↑ "NACD Board of Directors". www.nacdonline.org. Retrieved September 16, 2020.
  7. ↑ American Enterprise Institute Board of Trustees
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.